The advantages and mechanism of the treatment of unstable angina pectoris from 'Yu-Du (silted toxin)' based therapy of TCM theory

Phase 1

Completed

• Conditions: Coronary Heart Disease

• Registration Number: ITMCTR1900002489
• Lead Sponsor: Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the unstable angina and non ST segment elevation myocardial infarction diagnosis and treatment guidelines of the early hairstyle exertional angina, deteriorating exertional angina, spontaneous angina or mixed angina patients;
The clinical risk stratification standard is low and middle critical.
2. angina severity classification for I, II, and III;
3. The TCM syndrome differentiation is the heat - toxic blood stasis type;
4. Aged between 18 and 75 years old;
5. Been sign informed consent.

Exclusion Criteria

1. The patients with high risk or angina classification in the clinical risk stratification were classified as patients;
2. The combined hypertension was more than 180/100mmhg;
3. The electrocardiogram had st-segment elevation, serious arrhythmia, and moderate or above cardiac dysfunction (EF < 40%);
4. Severe shock, liver, kidney, lung, etc.
5. In the past 3 months, AMI history or percutaneous coronary angioplasty (PTCA), coronary artery bypass surgery (CABG), severe trauma, cerebrovascular accident;
6. Obvious infection, fever, severe anemia;
7. Women who are pregnant or lactating;
8. It is difficult to complete hospitalization continuous observer due to poor compliance.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
interleukin 10;Tumor necrosis factor;High-sensitive C reactive protein;Interleukin 6;adiponectin;